Network
The Network
Signals Platform
Analysis Platform
The Best Traders
Signals Platform
FOREX Signals Explained
Forex Signals
Commodities Signals
Crypto Signals
US Stocks Signals
Indices Signals
Markets
Exchange Rates
Commodity Prices
Cryptocurrency Prices
US Stocks Rates
Indices
News
The Newest News
FOREX News
Commodity News
Stocks News
Cryptocurrency News
Economy News
Trading Brokers
Forex Brokers List
Best Stock Brokers 2024
User Reviews for Brokers
Tools
Risk Calculator
Pips Calculator
Advance Chart
Blog
The Entire Blog
Trading Brokers
FOREX for Beginners
Crypto
Regulations
Articles
Stock Brokers
Trading For Beginners
Stocks
Search
A
ع
العربية
English
Home
/
Stocks
/
MTNB
M
Matinas BioPharma Holdings
D
Quotes are delayed by 15 minutes
MTNB
2.33700
USD
0.69
(42.07%)
Market Closed
Volume
525,970
EPS
-2
Div Yield
-
P/E
-1
Market Cap
11,888,284
Overview
Signals
Ideas
News
Today
42.07%
1 Week
112.45%
1 Month
135.97%
6 Months
281.80%
12 Months
-69.45%
Year To Date
358.24%
All Time
0.00%
Related Instruments
Prev
A
AXSM
0.460
(0.42%)
109.210
USD
D
DRRX
0.01000
(0.53%)
1.90500
USD
P
PLX
-0.04000
(-2.64%)
1.47500
USD
T
TNDM
0.160
(1.50%)
10.810
USD
More
Skip to next slide page
News
Prev
Treasury Yields Decline as Market Anticipates Fed Rate Cuts
11 months ago
Economy News
Novo Nordisk Surges in Profit and Sales
1 year ago
Stocks News
More
Skip to next slide page
Title:
Matinas Biopharma Holdings Inc
Sector:
Healthcare
Industry:
Biotechnology
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
Do you need help or have a question?
Contact Us
Close